(XMME) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BTJRMP35
XMME: Emerging Markets, Equity, Shares, Financial, Instruments
The Xtrackers MSCI Emerging Markets UCITS ETF 1C (XETRA:XMME) is a Germany-domiciled ETF designed to provide exposure to emerging market equities. It tracks the Morningstar Emerging Markets Target Market Exposure Net Return USD Index, offering a diversified portfolio of companies from emerging economies. The fund is structured as a UCITS-compliant ETF, making it accessible to European investors seeking global diversification.
From a technical perspective, XMME is currently trading at 51.19 EUR, slightly above its 20-day SMA of 50.92 but below its 50-day SMA of 53.78. The 200-day SMA of 53.82 indicates a recent downtrend. The Average True Range (ATR) of 1.09 reflects moderate volatility, while the 20-day average volume of 68,754 shares suggests consistent liquidity.
Fundamentally, the ETF manages an AUM of 5.417 billion EUR, underscoring its popularity among investors seeking emerging market exposure. Its focus on broad market representation aligns with long-term growth strategies in developing economies.
3-Month Forecast: - Technical Outlook: Support is expected near the 200-day SMA of 53.82, with resistance at the 50-day SMA of 53.78. A break above resistance could signal a bullish reversal, while a breach of support may lead to further declines. - Fundamental Outlook: Emerging markets may face headwinds from tightening global monetary policies but could benefit from easing inflation and a weaker USD. The ETFs AUM is likely to remain stable, reflecting its role as a core holding for emerging market exposure.
Additional Sources for XMME ETF
XMME ETF Overview
Market Cap in USD | 6,086m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2017-06-21 |
XMME ETF Ratings
Growth Rating | 25.3 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -18.2 |
Analysts | - |
Fair Price Momentum | 48.18 EUR |
Fair Price DCF | - |
XMME Dividends
Currently no dividends paidXMME Growth Ratios
Growth Correlation 3m | -2.6% |
Growth Correlation 12m | 37.8% |
Growth Correlation 5y | 20.3% |
CAGR 5y | 5.47% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | 0.39 |
Alpha | -2.81 |
Beta | 0.636 |
Volatility | 13.55% |
Current Volume | 49.2k |
Average Volume 20d | 51.6k |
As of June 01, 2025, the stock is trading at EUR 53.96 with a total of 49,179 shares traded.
Over the past week, the price has changed by -1.56%, over one month by +4.68%, over three months by -5.14% and over the past year by +5.55%.
Neither. Based on ValueRay´s Analyses, Xtrackers MSCI Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 25.25 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XMME is around 48.18 EUR . This means that XMME is currently overvalued and has a potential downside of -10.71%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, XMME Xtrackers MSCI Emerging will be worth about 54.7 in June 2026. The stock is currently trading at 53.96. This means that the stock has a potential upside of +1.32%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 54.7 | 1.3% |